GLN is decomposed into glutamate by glutaminase, which is decomposed into -KG by glutamate dehydrogenase to participate in the tricarboxylic acid cycle [7, 30], affecting the occurrence of related diseases
Followed by Semaglutide 1.0mg [1.44% (95% CI: 1.69%, 1.19%)], Dulaglutide 4.5mg [1.16% (95% CI: 1.42%, 0.90%)], Semaglutide 0.5mg [1.11 (95% CI: 1.40, 0.82)], Dulaglutide 3.0mg [1.02 (95% CI: 1.28, 0.76)], PEX168 200ug [1.09 (95% CI: 1.45, 0.73)], Exenatide 2.0mg [1.06 (95% CI: 1.48, 0.63)], Dulaglutide 1.5mg [0.91 (95% CI: 1.13, 0.69)], PEX168 100ug [0.94 (95% CI: 1.28, 0.59)] and Dulaglutide 0.75mg [0.75 (95% CI: 1.01,0.49)]
The conclusions of these studies were also consistent with the statistical results of our article
doi: 10.1007/s00210-024-03179-4 166 MehtaSBoyerTLAkhtarSHeTZhangCVedadghavamiAet al
Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show